ReviewFrontiers in bioengineering and biotechnology2026
Recent advances in the delivery of natural-product antioxidants for the treatment of breast cancer.
Review in Frontiers in bioengineering and biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Breast cancer is one of the main causes of cancer-related death worldwide in women. Conventional treatment of breast cancer, including surgery and chemotherapy, face challenges such as tumor resistance, damaged organs due to the cytotoxicity of anticancer drugs, and poor drug circulation. Recently, several drug delivery vehicles have been developed for targeted breast cancer therapy enhancing drug bioavailability, solubility, and penetration while minimizing side effects and toxicity. In addition to chemotherapeutic drugs, antioxidants derived from plants have gained attention as promising agents for the treatment of breast cancer. This review explores the effect of natural product antioxidants on breast cancer and summarizes state-of-the-art studies utilizing various drug delivery systems to enhance the delivery of antioxidants to breast cancer.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.